(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide,
102767-31-7,
UNII-3P8M8S76NM,
3P8M8S76NM,
N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide, (S)-,
(S)-N-[1-(Aminocarbonyl)propyl]-4-chlorobutanamide,
Levetiracetam related compound A,
Levetiracetam related compound A [USP],
Levetiracetam Impurity 3,
SCHEMBL5836749,
Butanamide, N-((1S)-1-(aminocarbonyl)propyl)-4-chloro-,
DTXSID10145496,
N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide, (-)-,
QBJNYRYTZPBHFT-LURJTMIESA-N,
ZINC22005942,
AKOS027320653,
SC-48390,
FT-0661970,
(S)-N-[1-(aminocarbonyl)propy]-4-chlorobutanamide,
J-000782,
N-[(1S)-1-(Aminocarbonyl)propyl]-4-chlorobutanamide,
Levetiracetam Related Compound A, United States Pharmacopeia (USP) Reference Standard,